Home
Bernt Bøgvald Aarli's picture

Bernt Bøgvald Aarli

Associate Professor, Head of the Medical Skills Centre at the Faculty of Medicine. Pulmonologist and senior consultant at the Department of Thoracic Medicine, Haukeland University Hospital.
  • E-mailBernt.Aarli@uib.no
  • Visitor Address
    Department of Thoracic Medicine
    Haukeland University Hospital
    5021 BERGEN
  • Postal Address
    Postboks 7804
    5020 Bergen

Expertises

Specialist in pulmonology and internal medicine. Clinical researcher.

Main research areas

My research interests has been divided between obstructive pulmonary diseases, cystic fibrosis, and covid-19. 

COPD

My Ph.D. thesis from 2018 explored tidal Expiratory flow limitation in patients with stable COPD detected non-invasively with impulse oscillometry in the Bergen COPD Cohort Study (BergenCOPD). We also presented  normal values for within-breath oscillometric indices in elderly. Later projects on COPD has been investigating the use of a digital clinical decision-support system in the management of COPD. Presently we cooperate with Helse i Hardanger with a project investigating if a 3-days comprehensive concentrated interdisciplinary group rehabilitation program with a digital follow-up can give lasting behavioral changes in patients with COPD leading to more physical activity.

Asthma 

In my clinical position at Haukeland University Hospital we have created a registry for patients with severe asthma on biologic therapy. We cooperate with the International Severe Asthma Registry. I am the Norwegian delegate in the Nordic Severe Asthma Network (NSAN) and in the steering commettee of the NORDSTAR research project. Severeal publications have come  from the registry cooperation, NSAN, the and the NORDSTAR project. 

Cystic fibrosis

I have been a co-investigator in the Vertex, VX20-121-103 study on CFTR-modulator therapy which sparked reasearch interest for this patient group in my department. We currently have a projects on nutrition and physiotherapy in patients with cystic fibrosis where we compare the situation before and after the patient was put on CFTR-modulator therapy.

Post covid fatigue

Following the SARS-CoV-2 pandemic, a large number of patients suffer from long COVID with fatigue as one of the most commonly reported symptoms, impacting level of functioning, quality of life and ability to work. We are cooperating with Helse i Hardanger with a project investigating the effect of a 3-days comprehensive concentrated interdisciplinary group rehabilitation program in patients in patients with long COVID fatigue.

Teaches respiratory medicine to the medical students at the University of Bergen for the following classes of medicine: MED4MED5MED6, and MED12. Formativ OSKE for MED5.

Academic article
  • Show author(s) (2024). Trends in Non-Tuberculous Mycobacterial Lung Disease and Treatment Outcomes in a Low-Tuberculosis Prevalence Setting: A Retrospective Analysis. Pathogens.
  • Show author(s) (2024). First trans-diagnostic experiences with a novel micro-choice based concentrated group rehabilitation for patients with low back pain, long COVID, and type 2 diabetes: a pilot study. BMC Medicine.
  • Show author(s) (2023). Severe asthma trajectories in adults: findings from the NORDSTAR cohort. European Respiratory Journal.
  • Show author(s) (2023). Relationship between exercise capacity and fatigue, dyspnea, and lung function in non-hospitalized patients with long COVID. Physiological Reports.
  • Show author(s) (2023). Prevalence and management of severe asthma in the Nordic countries: findings from the NORDSTAR cohort. European Respiratory Journal Open Research (ERJ Open Research).
  • Show author(s) (2023). Multidisciplinary approaches to identifying and managing global airways disease: Expert recommendations based on qualitative discussions. Frontiers in Allergy. 11 pages.
  • Show author(s) (2023). Adult Severe Asthma Registries: A Global and Growing Inventory. Pragmatic and Observational Research. 127-147.
  • Show author(s) (2023). A safe and effective micro-choice based rehabilitation for patients with long COVID: results from a quasi-experimental study. Scientific Reports.
  • Show author(s) (2023). A prospective study of pulmonary outcomes and chest computed tomography in the first year after COVID-19. European Respiratory Journal Open Research (ERJ Open Research). 11 pages.
  • Show author(s) (2022). The course and determinants of post-traumatic stress over 12 months after hospitalization for COVID-19. Frontiers in Psychiatry. 7 pages.
  • Show author(s) (2022). Eosinophilic airway diseases: basic science, clinical manifestations and future challenges. European Clinical Respiratory Journal.
  • Show author(s) (2022). Changes in cardiopulmonary exercise capacity and limitations 3-12 months after COVID-19. European Respiratory Journal. 12 pages.
  • Show author(s) (2022). A novel concentrated, interdisciplinary group rehabilitation program for patients with chronic obstructive pulmonary disease: Protocol for a nonrandomized clinical intervention study. Journal of Medical Internet Research. 1-10.
  • Show author(s) (2021). Role of a Digital Clinical Decision-Support System in General Practitioners' Management of COPD in Norway. The International Journal of Chronic Obstructive Pulmonary Disease.
  • Show author(s) (2021). Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis. British Journal of Haematology. 542-546.
  • Show author(s) (2021). Evaluation of novel concentrated interdisciplinary group rehabilitation for patients with chronic illnesses: Protocol for a nonrandomized clinical intervention study. JMIR Research Protocols. 1-13.
  • Show author(s) (2021). COPD - do the right thing. BMC Family Practice. 17 pages.
  • Show author(s) (2020). Spirometry in chronic obstructive pulmonary disease in Norwegian general practice. BMC Family Practice. 1-6.
  • Show author(s) (2020). NORDSTAR: paving the way for a new era in asthma research. European Respiratory Journal. 7 pages.
  • Show author(s) (2020). Effect of stimulating waveform and of data processing on respiratory impedance measurement. Physiological Measurement. 9 pages.
  • Show author(s) (2020). Dyspnoea, lung function and CT findings three months after hospital admission for COVID-19. European Respiratory Journal.
  • Show author(s) (2017). The association of tidal EFL with exercise performance, exacerbations, and death in COPD. The International Journal of Chronic Obstructive Pulmonary Disease. 2179-2188.
  • Show author(s) (2017). Median regression spline modeling of longitudinal FEV1 measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients. PLOS ONE. 1-13.
  • Show author(s) (2015). Å være luftstrømsbegrenset i hvile. BestPractice Lungemedicin.
  • Show author(s) (2015). Variability of within-breath reactance in COPD patients and its association with dyspnoea. European Respiratory Journal. 625-634.
  • Show author(s) (2013). Reference values for within-breath pulmonary impedance parameters in asymptomatic elderly. Clinical Respiratory Journal. 245-252.
Academic lecture
  • Show author(s) (2023). Micro-choice based rehabilitation for patients with long COVID - long term follow-up .
Doctoral dissertation
  • Show author(s) (2018). Tidal Expiratory Flow Limitation: A new method for evaluating pulmonary function in elderly and patients with Chronic Obstructive Pulmonary Disease .
Interview
  • Show author(s) (2023). Alvorlig astma - det er hjelp å få. Persontilpasset behandling.
Poster
  • Show author(s) (2023). Micro-choice based rehabilitation for patients with post COVID-19 condition – a 3-month follow-up study. .
  • Show author(s) (2023). Micro-choice based rehabilitation for patients with post COVID-19 condition – a 3-month follow-up study.
  • Show author(s) (2022). The prevalence of severe asthma, use of oral corticosteroid and management strategies in the Nordic countries: results from the pan-Nordic NORDSTAR cohort.
  • Show author(s) (2016). Therapeutic choices for COPD following the revised GOLD guidelines.
  • Show author(s) (2016). Longitudinal changes in Peak Oxygen Uptake in Chronic Obstructive Pulmonary Disease (COPD) Patients with Dynamic Hyperinflation and/or Tidal Expiratory Flow Limitation.
  • Show author(s) (2014). Mortality In COPD Patients With Increased Intrabreath Reactance.
  • Show author(s) (2014). Flow limitation during resting breathing is associated with reduced exercise capability in COPD.
  • Show author(s) (2013). Can intra-breath variations of reactance predict dyspnea?
  • Show author(s) (2012). Longitudinal Variability Of Expiratory Flow Limitation (EFL) In COPD Patients And Healthy Smokers Detected Non-invasively By Impulse Oscillometry.
  • Show author(s) (2012). Exacebation history in COPD patients with and without expiratory flow limitation (EFL).
  • Show author(s) (2011). Expiratory flow limitation (EFL) detected non-invasively as a phenotypic characteristic of COPD.
  • Show author(s) (2010). Reference values for resistance and reactance measures from Impuls Oscillometry in healthy elderly.
  • Show author(s) (2009). Within-day repeatability and signal to noise ratio for IOS parameters and FEV1 in smokers with and without COPD.
Article in business/trade/industry journal
  • Show author(s) (2023). Ny behandling av cystisk fibrose. Indremedisineren.
  • Show author(s) (2022). Alvorlig astma. Indremedisineren.
  • Show author(s) (2015). Å være luftstrømsbegrenset i hvile. BestPractice. Lungemedisin.
Chapter
  • Show author(s) (2013). Utryddelse av tuberkulosen? Et tilbakeblikk over de siste 25 år. 145-154. In:
    • Show author(s) (2013). Norsk lungehelse. Norsk forening for lungemedisin.

More information in national current research information system (CRIStin)